Detection of FGFR Alterations in Urothelial Carcinoma: Current Diagnostic Methodologies, Technical Considerations and Future Perspectives

This publication has 78 references indexed in Scilit:

• FGFR1/3 Signaling as an Achilles’ Heel of Phenotypic Diversity in Urothelial Carcinoma
  European Urology Oncology, 2025
• Integrating multi-omics and machine learning for disease resistance prediction in legumes
  Theoretical and Applied Genetics, 2025
• Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial Cancer
  European Urology, 2024
• New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
  Clinical and Translational Oncology, 2022
• FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias
  European Urology, 2022
• Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition (EMT) markers for prognosis in high‐risk non‐muscle‐invasive (HGT1) bladder cancer
  The Journal of Pathology: Clinical Research, 2020
• NMR backbone assignments of the tyrosine kinase domain of human fibroblast growth factor receptor 3 in apo state and in complex with inhibitor PD173074
  Biomolecular NMR Assignments, 2018
• Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors
  Cancer Genetics, 2016
• Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer
  Virchows Archiv, 2014
• FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
  Cancer Medicine, 2014